Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

GALT RSS Feed
Add GALT Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator 123tom
Search This Board:
Last Post: 8/19/2014 4:56:36 PM - Followers: 44 - Board type: Free - Posts Today: 0

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources.

Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy.
 

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Though we do not have any current marketed products, our research and development programs, designed to ultimately help patients and their physicians, are focused on:

 

Fibrosis

 

Fibrosis is the development of excess fibrous connective tissue in an organ when exposed to a chronic disease. The longer the disease affects the organ, the more fibrous tissue is deposited and this ultimately results in the failure of the organ. Galectin Therapeutics’ drug candidates provide a promising and exciting new approach for the treatment of fibrotic diseases, including liver, lung and kidney fibrosis. Significant unmet need exists for treatment options in fibrosis. For example, there are currently no approved medical treatments available for the millions of patients in the U.S. who have non-alcoholic steatohepatitis with advanced fibrosis – commonly known as fatty liver disease. Learn about fibrosis and our research in this area including galectin effects on liver fibrosis, lung fibrosis and kidney fibrosis.

 

Cancer

 

Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Research shows the potential for galectin inhibition to play an important role in cancer therapy, particularly tumor immunotherapy – an emerging treatment that enhances the activity of the immune system against cancer cells. There are more than 100 types of cancers, and for many of these cancers, few treatment options exist. Our drug candidates provide a new and complimentary approach to other drugs on the market for the treatment of cancer. Learn more about cancer and immunotherapy.

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GALT
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for GALT
GALT News: Statement of Changes in Beneficial Ownership (4) 11:30 AM
GALT News: Statement of Changes in Beneficial Ownership (4) 08/18/2014 10:11:46 AM
GALT News: Statement of Changes in Beneficial Ownership (4) 08/15/2014 09:04:29 AM
GALT News: Statement of Changes in Beneficial Ownership (4) 08/15/2014 09:03:58 AM
GALT News: Statement of Changes in Beneficial Ownership (4) 08/14/2014 10:37:21 AM
News News Alert: Statement of Changes in Beneficial Ownership (4) 08/20/2014 11:30:20 AM
PostSubject
#1399   Stair steps of resistance overhead...... 123tom 08/19/14 04:56:36 PM
#1398   GALT price holding support at 4.50 today...... 123tom 08/19/14 03:54:00 PM
#1396   The guy already owns a ton and he's thefamilyman 08/19/14 11:11:37 AM
#1395   Geez - you rag on the CEO for nsomniyak 08/19/14 09:25:24 AM
#1394   Form 4 CEO buys 20,000$ stock. That little? Adi2 08/19/14 04:32:53 AM
#1393   yeah.....geez, I'm afraid to look at That one 123tom 08/17/14 09:59:58 PM
#1392   There's also a gap at about 3.63, lol. tradervader 08/17/14 09:49:09 PM
#1391   well, tvader...... okay, .... if you want 123tom 08/17/14 09:44:20 PM
#1390   Investor Info for GALT http://galt.freeforums.net/thread/2/galectin-therapeuti DirectionalDriller 08/17/14 01:09:57 AM
#1389   RSI 27.58. Oversold and room to run tradervader 08/15/14 04:30:35 PM
#1388   MACD -.146. getting closer to a flip tradervader 08/15/14 04:29:55 PM
#1387   Closed above the 5day sma for the first tradervader 08/15/14 04:27:47 PM
#1386   GALT fundamentals........ 123tom 08/15/14 03:20:06 PM
#1385   Thank you, Darwin!!! pugdaddy 08/15/14 03:04:18 PM
#1381   What was the short interest in the stock davidc2 08/15/14 01:44:23 PM
#1375   *GALT's management is terrible! They aren't even fit Darwinian 08/15/14 10:44:29 AM
#1369   More insider buying at GALT biotech2010 08/15/14 09:39:06 AM
#1361   Thank you, you just validated my appreciation for davidc2 08/14/14 10:20:11 PM
#1360   I'm not sure what to make of the Darwinian 08/14/14 10:11:47 PM
#1359   I'm not quite sure what you're saying or Darwinian 08/14/14 10:09:36 PM
#1358   Obviously 1K shares is nothing. Especially at this davidc2 08/14/14 09:50:03 PM
#1357   I look at Level 2 quotes often with biotech2010 08/14/14 11:49:37 AM
#1356   "Institutional holdings have now increased to 20.96%." mx10001 08/14/14 11:03:44 AM
#1355   It also looks like Mr. Traber purchased 1,000 Darwinian 08/14/14 11:01:08 AM
#1354   http://www.ncbi.nlm.nih.gov/pubmed/?term=Galectin+therapeutics DirectionalDriller 08/14/14 10:58:30 AM
#1353   Institutional holdings have now increased to 20.96%. thefamilyman 08/14/14 10:52:17 AM
#1352   Thx for posting, I saved it. Anything else davidc2 08/14/14 09:11:04 AM
#1348   http://galectintherapeutics.com/wp-content/uploads/2014/01/2013-Traber-et-al-PLO DirectionalDriller 08/14/14 12:13:56 AM
#1347   David this company is a fire sale here. DirectionalDriller 08/13/14 11:37:08 PM
#1346   Please post any links to anything you think davidc2 08/13/14 11:34:16 PM
#1345   Your analysis below is THE most relevant piece thefamilyman 08/13/14 11:30:49 PM
#1344   Tom, reading the report it just seems to davidc2 08/13/14 11:11:04 PM
#1343   Who is really preying on ill informed investors. DirectionalDriller 08/13/14 11:09:51 PM
#1342   Hi pugdaddy, Darwinian 08/13/14 09:10:59 PM
#1341   Where is this report?? I'd like to pugdaddy 08/13/14 08:56:31 PM
#1340   Nah. It's been around a while and is Darwinian 08/13/14 05:44:53 PM
#1337   Darwin, do you have a more updated fundamental 123tom 08/13/14 04:42:16 PM
#1333   If things are so great why did the thefamilyman 08/13/14 03:46:27 PM
#1332   fatty liver dz has many causes, and until oldsport 08/13/14 03:34:49 PM
#1330   Gap around 3.63 could be the down side tradervader 08/13/14 12:12:48 PM
#1326   If things are so great why did the davidc2 08/13/14 10:09:21 AM
#1325   Institutional holdings have increased to 20.07%. thefamilyman 08/13/14 09:53:19 AM
#1322   excellent reply. 123tom 08/13/14 03:35:55 AM
#1321   ......oldsport, now thats the kind of good fortune 123tom 08/13/14 03:33:09 AM
#1320   go back read each initial phase results, their oldsport 08/13/14 01:48:55 AM
#1319   You said that a week ago almost 25% davidc2 08/12/14 10:52:40 PM
#1318   short interest would love to see price go oldsport 08/12/14 10:08:53 PM
#1317   And definitely be sure not to waste your davidc2 08/12/14 09:54:41 PM
#1313   "I thought his subsequent comment, "and then I sunspotter 08/12/14 07:58:00 PM
#1312   Why is this a "quasi-biopharma" in your opinion? Also davidc2 08/12/14 07:52:29 PM
PostSubject